Menu

Merck, Eisai and Vertex will refund 340B covered entities that purchased certain medications between 2022 and 2025, according to notices posted on HRSA's website.

Merck, Eisai, Vertex to Refund 340B Covered Entities for Overcharges

July 29, 2025 Shannon Young, Managing Editor 340B Report Views

Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Record Turnout for Fourth Annual ‘Defend 340B’ March on Capitol Hill

Alkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions